Bg pattern

Canesmycospor onicoset 10mg/ g + 400mg/g pomada

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Canesmycospor onicoset 10mg/ g + 400mg/g pomada

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Label: Patient Information

CanesMycospor Onicoset 10 mg/g + 400 mg ointment

Bifonazol / urea

Read this label carefully before starting to use this medication, as it contains important information for you.

  • Keep this label, as you may need to refer to it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed only for you, and you should not give it to others who have the same symptoms as you, as it may harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this label. See section 4.

Contents of the package and additional information

1. What is CanesMycospor Onicoset and what is it used for

This medication has two active ingredients, bifonazole (an antifungal) used for the treatment of superficial skin infections caused by fungi and yeast, and urea, an emollient used for the softening of the infected nail.

It is used to remove infected nails in a non-traumatic (non-bleeding) manner, and simultaneously eliminates the infection caused by fungi.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use CanesMycospor Onicoset

Do not use CanesMycospor Onicoset:

  • if you are allergic to bifonazol, imidazoles in general, or to any of the other components of this medication (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use CanesMycospor Onicoset.

  • this medication is only forexternal use. Avoid contact with the eyes and mucous membranes, and in case of contact, rinse them with cold water,
  • do not ingest,
  • if a hypersensitivity reaction or allergic reaction develops during treatment, discontinue treatment and consult your doctor,
  • in rare cases, the dressing may cause an allergic reaction; in that case, switch to another type of dressing or use a rubber glove.

Children

The safety and efficacy have not been established in the pediatric population.

Using CanesMycospor Onicoset with other medications

Inform your doctor or pharmacist if you are using or have recently used other medications or may need to take any other medication.

If you are being treated with warfarin (oral anticoagulant), your dose may need to be adjusted as the effects of this medication may be affected by the use of bifonazol.

It is not recommended to use other medications in the same areas where this medication is applied.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Pregnancy

This medication is not recommended during pregnancy or in women of childbearing age who are not using contraceptive methods.

Breastfeeding

Caution should be exercised during breastfeeding, as bifonazol or urea may be excreted in breast milk. In the event of administration, natural breastfeeding should be interrupted and replaced.

Driving and operating machinery

The influence of this medication on the ability to drive and operate machinery is negligible or insignificant.

CanesMycospor Onicoset contains lanolin

This medication may cause local skin reactions (such as contact dermatitis) because it contains lanolin.

3. How to Use CanesMycospor Onicoset

Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Recommended dose:

Apply once a day to the infected nail, in sufficient quantity to cover the entire surface of the nail with a thin layer of ointment.

The treatment with the ointment should be applied carefully every day and should continue until no more fungus-infected nail substance can be lifted.

Usually, treatment lasts from 7 to 14 days, depending on the extent of the infection and the thickness of the nail.

Administration form:

Cutaneous use

Before the first application of the ointment, soak the infected nail in warm water for a few minutes to slightly soften the nail to be treated, and then dry it well. Apply the ointment to the infected nail, covering its surface with a thin layer. Then, the treated finger or toe will be covered with a dressing that will be left in place for 24 hours. After these 24 hours, the dressing will be removed and the affected finger will be washed for 10 minutes in warm water. After this wash, the softened part of the treated nail will be removed with the scraper included in the package; the treated nail will be dried and the ointment will be reapplied as described before, covering the nail with a new dressing until the next day.

No need to cover the skin around the nail. However, if irritation is observed, which is exceptional, before placing the dressing, the skin around the nail can be covered with an appropriate product such as zinc paste.

Once the nail is removed, the treatment should continue with another antifungal product to eliminate the fungus from the skin layer located under the nail. Before this, the doctor should evaluate if the infected part of the nail has been completely removed and, if necessary, perform a final cleaning of the area.

It is recommended to wash your hands after each application.

General hygiene measures should be taken to avoid the appearance of other infections or recurrences.

Usage instructions

1. Soak the foot or hand in warm water and dry well.

2. Squeeze the tube slowly until a portion of ointment of the same length as the affected nail comes out. Apply the portion of ointment to the nail without pressing or massaging.

3. Place half of the dressing under the finger. The dressings can be cut to the size of the nail.

4. Fold the sides of the dressing upwards and press them well against the finger.

5. Then, place the remaining half of the dressing over the nail, folding the adhesive surfaces downwards and pressing.

6. Now the dressing is placed as a protective covering over the affected nail. Thus, the nail is kept for 24 hours with the dressing.

7. After 24 hours, the dressing is removed, the foot or hand is soaked in warm water for 10 minutes, and then washed and dried well.

8. With the scraper included, the softened nail is carefully removed.

The treatment following these instructions carefully should be repeated daily until all the infected nail is removed, which usually occurs within 7-14 days.

CanesMycospor Onicoset acts only on the infected nail, without affecting unaffected areas.

Once the nail is removed, treatment should continue with an appropriate antifungal product.

If you use more CanesMycospor Onicoset than you should

If you apply more ointment than your doctor has indicated, you may feel a burning sensation, redness, or swelling that will disappear after stopping treatment.

This medication should not be ingested. If ingested accidentally, contact your doctor.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or go to a medical center immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

If you forgot to use CanesMycospor Onicoset

If you forgot to use this medication when it was due, apply the ointment as soon as you remember and continue with your usual treatment regimen. Do not use a double dose to compensate for the missed doses.

If you interrupt the treatment with CanesMycospor Onicoset

Do not stop treatment before your doctor indicates, as irregular use or premature interruption of treatment carries the risk of recurrence.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Adverse Effects

Like all medications, this medication may produce adverse effects, although not all people will experience them.

The following adverse effects have been described, whose frequency cannot be estimated from the available data (unknown frequency):Contact dermatitis (skin inflammation), erythema (skin inflammation and redness), pruritus, exanthema (rash), skin exfoliation (skin peeling), skin irritation, skin maceration, nail disorders or changes in color, pain at the application site, and pain in the extremity.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicinal Products for Human Use:https://notificaram.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.

5. Conservation of CanesMycospor Onicoset

Keep this medication out of the sight and reach of children.

Do not store at a temperature above 86°F (30°C). Store in the original packaging.

The remaining medication in the tube should be discarded once the treatment period set by the doctor is completed, and in any case, within 3 months after opening. Once the container is opened, do not store at a temperature above 77°F (25°C).

Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.

Medicines should not be thrown away through drains or in the trash. Dispose of the containers, medical devicesand medications that you no longer need at the Sigre Pointof the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers,medical devicesand medications that you no longer need. In this way, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of CanesMycospor Onicoset

- The active principles are bifonazole and urea. Each gram of ointment contains 10 mg of bifonazole and 400 mg of urea.

- The other components (excipients) are: lanolin, white beeswax, and white petrolatum.

Appearance of the product and contents of the packaging

CanesMycospor Onicoset is a yellowish-colored ointment with no odor. It is presented in a cardboard box that contains inside: a cardboard box with a lacquered aluminum tube with a closed mouth and an HDPE screw cap containing 10 g of ointment, a package of hydrophobic (waterproof) adhesive dressings, and a nail scraper.

Holder of the marketing authorization and responsible for manufacturing

Holder of the marketing authorization

Bayer Hispania, S.L.

Av. Baix Llobregat, 3 – 5

08970 Sant Joan Despí (Barcelona)

Spain

Responsible for manufacturing

GP Grenzach Produktions GmbH

Emil-Barell-Str. 7

D-79639 Grenzach-Wyhlen

Germany

Revision date of this leaflet: April 2021

The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/

Online doctors for Canesmycospor onicoset 10mg/ g + 400mg/g pomada

Discuss questions about Canesmycospor onicoset 10mg/ g + 400mg/g pomada, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for Canesmycospor onicoset 10mg/ g + 400mg/g pomada?
Canesmycospor onicoset 10mg/ g + 400mg/g pomada requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in Canesmycospor onicoset 10mg/ g + 400mg/g pomada?
The active ingredient in Canesmycospor onicoset 10mg/ g + 400mg/g pomada is bifonazole. This information helps identify medicines with the same composition but different brand names.
Who manufactures Canesmycospor onicoset 10mg/ g + 400mg/g pomada?
Canesmycospor onicoset 10mg/ g + 400mg/g pomada is manufactured by Bayer Hispania S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of Canesmycospor onicoset 10mg/ g + 400mg/g pomada online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Canesmycospor onicoset 10mg/ g + 400mg/g pomada is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to Canesmycospor onicoset 10mg/ g + 400mg/g pomada?
Other medicines with the same active substance (bifonazole) include CANESMYCOSPOR 10 mg/g CREAM, CANESPIE BIFONAZOL 10 mg/g CREAM, CANESPIE BIFONAZOL 10 mg/ml CUTANEOUS SPRAY SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media